AEA RC T Registr y

The American Economic Association's registry for randomized controlled trials

We will contact previously-convicted people prior to fall municipal elections, offering them information about eligibility to vote and a registration form and stamped envelope to return that form to the board of elections.

We will scale up the previous pilot study for a larger trial prior to the 2020 general election. We use a between-subjects design with five groups: 1) control (uncontacted); 2) contacted with a letter from our partner organization with felony-targeted introductory language, information about eligibility, a registration form and stamped envelope; 3) treatment 2 minus the felony-targeted introductory language; 4) treatment 2 minus the registration form and envelope; 5) treatment 2 plus a stronger encouragement to register that informs recipients of the importance of voting to elect representatives who will shape civil rights and criminal justice policies.

We are also conducting a second trial focusing on individuals who live in the same zip codes as those in our main study, but who administrative records do not indicate have previous felony convictions. We can use the results of this study to compare responses in our population of interest (those with previous convictions) to those in the broader population. This trial will have two arms: 1) control (uncontacted); 2) a letter from a partner or us with information about eligibility, plus a form + stamped envelope. (treatment arm 3 from the main study).

2019-08-28

2020-11-03

Voter registration (appearing on the state's public voter file) and voting in municipal elections where relevant, as well as longer-term voter participation in the next statewide election.

For the scaled up trial, we will collect the following outcome variables after each state’s voter registration deadline and after the 2020 General Election: voter registration and whether an individual casts a ballot in the election.


For the larger scaled up project we will also collect data for voting in the General Election.

We will randomly divide people in a sample of previously-convicted residents of North Carolina into two groups; the "control" group will not be contacted, while the "treatment" group will be sent a letter telling them about the voter registration process and encouraging them to register if eligible.

For the scaled-up study we will use a between-subjects design with five arms, one of which will be an (uncontacted) control group. The study will be fielded in North Carolina and Texas. We will randomize at the individual level with equal probability across the five treatment groups, blocking on state, using the "randomize" function from the "experiment" library in R. The comparison (no-record) group is randomized (individually) with equal probability into treatment and control.

Not available

Randomization done in office by a computer.

individual

For the scaled-up trial: individual, blocking on state

No

8,621 people for whom we have addresses in the initial sample.

Across the two trials all conditions and control groups, we expect a total sample size of about 160,703 individuals in the 2020 trial.

same as clusters (individual randomization)

people will be randomized with equal probability into treatment/control conditions (so n/2).

People will be randomized with equal probability into treatment/control conditions, blocking on state, for the 2020 expansion.

With respect to power, we have performed power calculations aimed at testing the sample size needed to identify differences between treatment arms. We assumed a baseline control-group registration rate of 2%, which was the average registration rate across all three of our pilot studies. We believe that in our main study, the sample size of 125,000 people, with 25,000 in control, should allow us to detect a minimum treatment effect of .28 percentage points. Comparing the control to any one of the treatment arms (each of which included 25,000 people) will allow us to detect a minimum treatment effect of .35 percentage points. These minimal detectable effects are substantially smaller than the effects we saw in our pilot studies. In our second study, with a total of 35,708 individuals equally split between treatment and control, we should be able to detect a minimum treatment effect of .41 percentage points.